The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1).
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D011342:Procainamide / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011802:Quinidine / Q000494:pharmacology*; D011817:Rabbits; D011930:Reaction Time / Q000187:drug effects; D014132:Trachea / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000588:Amines; D000889:Anti-Arrhythmia Agents; D009281:Naphthalenes; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D007545:Isoproterenol; D004837:Epinephrine